Show simple item record

dc.contributor.authorGrandesso, F
dc.contributor.authorGuindo, O
dc.contributor.authorWoi Messe, L
dc.contributor.authorMakarimi, R
dc.contributor.authorTraore, A
dc.contributor.authorDama, S
dc.contributor.authorLaminou, IM
dc.contributor.authorRigal, J
dc.contributor.authorde Smet, M
dc.contributor.authorOuwe Missi Oukem-Boyer, O
dc.contributor.authorDoumbo, OK
dc.contributor.authorDjimdé, A
dc.contributor.authorEtard, JF
dc.date.accessioned2018-02-06T16:37:26Z
dc.date.available2018-02-06T16:37:26Z
dc.date.issued2018-01-25
dc.date.submitted2018-01-31
dc.identifier.citationEfficacy of artesunate-amodiaquine, dihydroartemisinin-piperaquine and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger. 2018, 17 (1):52 Malar. J.en
dc.identifier.issn1475-2875
dc.identifier.pmid29370844
dc.identifier.doi10.1186/s12936-018-2200-1
dc.identifier.urihttp://hdl.handle.net/10144/619072
dc.description.abstractMalaria endemic countries need to assess efficacy of anti-malarial treatments on a regular basis. Moreover, resistance to artemisinin that is established across mainland South-East Asia represents today a major threat to global health. Monitoring the efficacy of artemisinin-based combination therapies is of paramount importance to detect as early as possible the emergence of resistance in African countries that toll the highest burden of malaria morbidity and mortality.
dc.language.isoenen
dc.publisherBioMed Centralen
dc.rightsPublished by BioMed Central, [url]http://www.malariajournal.com/[/url] Archived on this site by Open Access permissionen
dc.titleEfficacy of artesunate-amodiaquine, dihydroartemisinin-piperaquine and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Nigeren
dc.identifier.journalMalaria Journalen
refterms.dateFOA2019-03-04T13:45:13Z
html.description.abstractMalaria endemic countries need to assess efficacy of anti-malarial treatments on a regular basis. Moreover, resistance to artemisinin that is established across mainland South-East Asia represents today a major threat to global health. Monitoring the efficacy of artemisinin-based combination therapies is of paramount importance to detect as early as possible the emergence of resistance in African countries that toll the highest burden of malaria morbidity and mortality.


Files in this item

Thumbnail
Name:
Grandesso et al - 2018 - Efficacy ...
Size:
1.117Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record